Results 181 to 190 of about 2,340,883 (315)

Economic sanctions, healthcare and the right to health. [PDF]

BMJ Glob Health, 2022
Germani F, März JW, Clarinval C, Biller-Andorno N.   +3 more
europepmc   +1 more source

A child's right to health [PDF]

The Lancet, 2019
Stefan, Peterson, Luwei, Pearson, Robin, Nandy, Debra, Jackson, David, Hipgrave   +4 more
openaire   +2 more sources

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Primary Care Service Provision Scale for Evaluating the Right to Health Among International Migrant Populations. [PDF]

Healthcare (Basel)
Cruz-Riveros C, Urzúa A, Lagos C, Parada E.   +3 more
europepmc   +1 more source

Implementing and monitoring the right to health in breast cancer: selection of indicators using a Delphi process. [PDF]

Int J Equity Health, 2023
Montel L, Coleman MP, Murphy T, Balabanova D, Ciula R, Evans DP, Lougarre C, Verhoeven D, Allemani C.   +8 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Front-of-package labelling: A public health imperative rooted in the right to health. [PDF]

Int J Equity Health
Radu YT, Mahomedy S.
europepmc   +1 more source

Engaging with the Right to Health: Ethnographic Explorations of the Right to Health in Practice [PDF]

Medical Anthropology, 2019
Alejandro Cerón, Jessica Jerome
openaire   +2 more sources

People who use drugs and the right to health. [PDF]

Harm Reduct J
Ritter A, Barrett L.
europepmc   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source